Literature DB >> 34213595

Exploring the link between chronobiology and drug delivery: effects on cancer therapy.

Tânia Albuquerque1, Ana R Neves1, Telma Quintela1, Diana Costa2.   

Abstract

Circadian clock is an impressive timing system responsible for the control of several metabolic, physiological and behavioural processes. Nowadays, the connection between the circadian clock and cancer occurrence and development is consensual. Therefore, the inclusion of circadian timing into cancer therapy may potentially offer a more effective and less toxic approach. This way, chronotherapy has been shown to improve cancer treatment efficacy. Despite this relevant finding, its clinical application is poorly exploited. The conception of novel anticancer drug delivery systems and the combination of chronobiology with nanotechnology may provide a powerful tool to optimize cancer therapy, instigating the incorporation of the circadian timing into clinical practice towards a more personalized drug delivery. This review focuses on the recent advances in the field of cancer chronobiology, on the link between cancer and the disruption of circadian rhythms and on the promising targeted drug nanodelivery approaches aiming the clinical application of cancer chronotherapy.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.

Entities:  

Keywords:  Cancer chronotherapy; Chronobiology; Circadian clock; Drug nanodelivery systems; Personalized nanomedicine

Mesh:

Substances:

Year:  2021        PMID: 34213595     DOI: 10.1007/s00109-021-02106-x

Source DB:  PubMed          Journal:  J Mol Med (Berl)        ISSN: 0946-2716            Impact factor:   4.599


  163 in total

Review 1.  Timing is important in medication administration: a timely review of chronotherapy research.

Authors:  Gagandeep Kaur; Craig Phillips; Keith Wong; Bandana Saini
Journal:  Int J Clin Pharm       Date:  2013-01-18

Review 2.  Circadian rhythms: mechanisms and therapeutic implications.

Authors:  Francis Levi; Ueli Schibler
Journal:  Annu Rev Pharmacol Toxicol       Date:  2007       Impact factor: 13.820

3.  Phase III trial comparing 4-day chronomodulated therapy versus 2-day conventional delivery of fluorouracil, leucovorin, and oxaliplatin as first-line chemotherapy of metastatic colorectal cancer: the European Organisation for Research and Treatment of Cancer Chronotherapy Group.

Authors:  Sylvie Giacchetti; Georg Bjarnason; Carlo Garufi; Dominique Genet; Stefano Iacobelli; Marco Tampellini; Rune Smaaland; Christian Focan; Bruno Coudert; Yves Humblet; Jean Luc Canon; Antoine Adenis; Giovanni Lo Re; Carlos Carvalho; Johannes Schueller; Nicole Anciaux; Marie-Ange Lentz; Benoît Baron; Thierry Gorlia; Francis Lévi
Journal:  J Clin Oncol       Date:  2006-08-01       Impact factor: 44.544

4.  Circadian clock-controlled drug metabolism and transport.

Authors:  Mengjing Zhao; Huijie Xing; Min Chen; Dong Dong; Baojian Wu
Journal:  Xenobiotica       Date:  2019-10-01       Impact factor: 1.908

5.  Regulation of clock-controlled genes in mammals.

Authors:  Katarzyna Bozek; Angela Relógio; Szymon M Kielbasa; Markus Heine; Christof Dame; Achim Kramer; Hanspeter Herzel
Journal:  PLoS One       Date:  2009-03-16       Impact factor: 3.240

Review 6.  Metabolism and cancer: the circadian clock connection.

Authors:  Saurabh Sahar; Paolo Sassone-Corsi
Journal:  Nat Rev Cancer       Date:  2009-12       Impact factor: 60.716

Review 7.  The circadian clock in cancer development and therapy.

Authors:  Loning Fu; Nicole M Kettner
Journal:  Prog Mol Biol Transl Sci       Date:  2013       Impact factor: 3.622

8.  New Insights Into the Circadian Rhythm and Its Related Diseases.

Authors:  Yanling Xie; Qingming Tang; Guangjin Chen; Mengru Xie; Shaoling Yu; Jiajia Zhao; Lili Chen
Journal:  Front Physiol       Date:  2019-06-25       Impact factor: 4.566

9.  Chronotherapy: Intuitive, Sound, Founded…But Not Broadly Applied.

Authors:  Julia M Selfridge; Tetsuya Gotoh; Samuel Schiffhauer; JingJing Liu; Philip E Stauffer; Andrew Li; Daniel G S Capelluto; Carla V Finkielstein
Journal:  Drugs       Date:  2016-10       Impact factor: 9.546

View more
  3 in total

1.  The Influence of Circadian Rhythm on Cancer Cells Targeting and Transfection Efficiency of a Polycation-Drug/Gene Delivery Vector.

Authors:  Tânia Albuquerque; Ana R Neves; Telma Quintela; Diana Costa
Journal:  Polymers (Basel)       Date:  2022-02-10       Impact factor: 4.329

Review 2.  Circadian Rhythm Dysregulation and Leukemia Development: The Role of Clock Genes as Promising Biomarkers.

Authors:  Ana Beatriz Aguiar Sanford; Leidivan Sousa da Cunha; Caio Bezerra Machado; Flávia Melo Cunha de Pinho Pessoa; Abigail Nayara Dos Santos Silva; Rodrigo Monteiro Ribeiro; Fabiano Cordeiro Moreira; Manoel Odorico de Moraes Filho; Maria Elisabete Amaral de Moraes; Lucas Eduardo Botelho de Souza; André Salim Khayat; Caroline Aquino Moreira-Nunes
Journal:  Int J Mol Sci       Date:  2022-07-26       Impact factor: 6.208

Review 3.  Chronodisruption and Ambulatory Circadian Monitoring in Cancer Patients: Beyond the Body Clock.

Authors:  Pedro F Almaida-Pagan; María Torrente; Manuel Campos; Mariano Provencio; Juan Antonio Madrid; Fabio Franco; Beatriz Rodríguez Morilla; Blanca Cantos; Pedro A Sousa; María José Martínez Madrid; Joao Pimentao; María Ángeles Rol
Journal:  Curr Oncol Rep       Date:  2022-01-21       Impact factor: 5.075

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.